149 related articles for article (PubMed ID: 15021932)
1. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].
Lewerenz V; Burchardt T; Büchau A; Ruzicka T; Megahed M
Hautarzt; 2004 Apr; 55(4):379-81. PubMed ID: 15021932
[TBL] [Abstract][Full Text] [Related]
2. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
Davis MD; Wysokinski WE
J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
[TBL] [Abstract][Full Text] [Related]
3. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
[TBL] [Abstract][Full Text] [Related]
4. Livedoid vasculopathy in a patient with factor V mutation (Leiden).
Biedermann T; Flaig MJ; Sander CA
J Cutan Pathol; 2000 Sep; 27(8):410-2. PubMed ID: 10955688
[TBL] [Abstract][Full Text] [Related]
5. Livedoid vasculopathy and its association with factor V Leiden mutation.
Yong AA; Tan AW; Giam YC; Tang MB
Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
Anavekar NS; Kelly R
Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
[TBL] [Abstract][Full Text] [Related]
7. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation.
Calamia KT; Balabanova M; Perniciaro C; Walsh JS
J Am Acad Dermatol; 2002 Jan; 46(1):133-7. PubMed ID: 11756961
[TBL] [Abstract][Full Text] [Related]
8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
[TBL] [Abstract][Full Text] [Related]
10. Atypical presentation of livedo racemosa in a factor V Leiden heterozygous positive patient with Pseudomonas aeruginosa urosepsis.
Johnston J; Noakes R; Davidson K
Australas J Dermatol; 2017 Aug; 58(3):e144-e147. PubMed ID: 27858977
[TBL] [Abstract][Full Text] [Related]
11. [Vasculitis and vasculopathy].
Marković A
Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
[TBL] [Abstract][Full Text] [Related]
12. Livedoid vasculopathy: A review of pathogenesis and principles of management.
Vasudevan B; Neema S; Verma R
Indian J Dermatol Venereol Leprol; 2016; 82(5):478-88. PubMed ID: 27297279
[TBL] [Abstract][Full Text] [Related]
13. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
Goerge T
Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
[TBL] [Abstract][Full Text] [Related]
14. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
Browning CE; Callen JP
Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
[TBL] [Abstract][Full Text] [Related]
15. Chronic leg ulcerations associated with livedoid vasculopathy successfully treated with rivaroxaban.
Miguel D; Elsner P; Goetze S
Clin Exp Dermatol; 2020 Jan; 45(1):120-122. PubMed ID: 30767258
[No Abstract] [Full Text] [Related]
16. Are low doses of enoxaparin with aspirin sufficient to guarantee good gestational outcome in women with heterozygote factor V Leiden mutation?
Monastiri K; Seket B; Chouchane S; Samama MM; Mahjoub T
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):138-40. PubMed ID: 16448739
[No Abstract] [Full Text] [Related]
17. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
Di Giacomo TB; Hussein TP; Souza DG; Criado PR
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1340-6. PubMed ID: 20337814
[TBL] [Abstract][Full Text] [Related]
18. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
[TBL] [Abstract][Full Text] [Related]
19. Primary livedoid vasculopathy associated with mononeuritis multiplex.
Krueger S; McLean R; Amano S; Belazarian L
Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898400
[TBL] [Abstract][Full Text] [Related]
20. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.
Thomassen MC; Castoldi E; Tans G; Magdeleyns EJ; Delaunoit C; Debusscher L; Van Assche KJ; Rosing J
Haematologica; 2003 Oct; 88(10):1150-6. PubMed ID: 14555311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
